Research Article

Evaluation of the Therapeutic Effect of Traditional Chinese Medicine on Osteoarthritis: A Systematic Review and Meta-Analysis

Table 1

Characteristics of eligible studies.

Author, yearCases T/CDiagnostic standardAge (years) range, meanSex male/female

OATCMWang Zhenhua, 201853/53GDTO and GPCRNDTCMT: 41–72, 50.17C: 43–74, 51.49T:29/24C: 31/22
Kuang Yao, 201849/42GDTO and DTSTCM95D22ST: 56.13C: 55.65T: 25/24C: 20/22
Wen Yangyang, 201963/63GDTO and GPCRNDTCMT: 61.98C: 62.61T: 32/31C: 36/27
Cui Hongfang, 201861/61GDTO and GPCRNDTCMT: 45–76, 64.7C: 46–75, 62.5T:31/31C: 32/29
Zheng Tao, 201950/50GDTO and CDTEDSTCMT: 52–67, 63.26C: 51–67T:27/23C: 24/26
Yuan Fang, 201830/30GDTO (2007) and CDTEDSTCMT: 42–72, 54.47C: 41–72, 60.63T: 4/26C: 6/24
Li Zhimin, 201848/48DCKO and CDTEDSTCMT: 47–78, 57.42C: 45–76, 58.24T: 29/19C: 31/17
Liu Sheng, 201950/50GDTO (2010) and TCMDTS95D22ST: 54–70, 58.34C:53–71, 57.43T: 25/25C: 26/24
Li Ping, 201974/74CETCMDTKOT: 47–73, 60.69C: 45–75, 59.48T: 24/50C: 25/49
Li Linzhong, 201440/40NRT: 42–75, 57.43C:41–74, 56.3132/48

EUTCMYu Ming, 201873/73DCKO (2007)43–80, 54.86T: 40/33C: 46/27
Li Meng, 201730/30DCKOT: 41–61, 52.41C: 42–60, 51.27T: 13/17C: 12/18
Lei Shoubin, 201449/49GDTOT: 43–70, 57.5C: 44–71, 58.7T: 17/32C: 18/31
Zeng Jiaofei, 201450/50DCKO and K–LT:45–63, 56.1C:45–65, 55.6T: 21/29C: 23/27
He Junlei, 201657/55DCKOT: 45–73, 58.61C: 43–75, 59.06T: 16/41C:19/36
Chen Xi, 201540/40DCKO and GDTO40–75, 61.235/45
Liu Enxiong, 201668/68GDTO and GPCRNDTCMT: 53–79, 61.29C: 51–78, 61.01T: 45/23C: 48/20
Zhou Gang, 201838/38GDTO (2007) and CDTEDSTCMT: 46–70, 55.62C: 45–68, 54.33T: 16/22C: 20/18
Lui Gui, 201760/60GDTO and GPCRNDTCMT: 59–72, 64.14C: 58–74, 64.29T: 19/41C: 21/39
Ding Liming, 201651/47NRT: 63.00C: 67.08T: 16/35C: 14/33
Zhang Yanzhen, 201834/34CDTEDSTCM and DCKO (1995)T: 42–73, 52.34C: 42–73, 54.24T: 12/22C: 10/24
Liu Yongyu, 201430/30DGDTOT: 51–69C: 51–69NRNR
Wang Yuan, 201830/30DCKO (1995)T: 40–74, 58.67C:44–73, 58.03T: 8/22C: 2/28
Zhang Zhi, 201852/51GDTO (2007) and K–LT: 55–68, 63.9C: 53–70, 64.8T: 24/28C: 24/27
Chen Hongmei, 201731/30DCKOT: 58.18C:55.90T: 13/18C: 11/19
Zhang Hui, 201651/51PO and TCMDTS95D22ST: 41–79, 57.2C: 40–78, 56.1T: 17/34C:19/32
Liu Lin, 201840/40DCCASTCMT: 40–70C: 40–70NRNR
Cui Shuping, 201635/35GDTO and GPCRNDTCMT: 42–78C: 46–80T: 14/21C: 12/20
Wang Tao, 201730/30GPCRNDTCM and GDTO &TCMDTS95D22ST: 42–57, 51.1C: 43–56, 50.2T: 8/22C: 9/21
Guo Wenhui, 201845/45DCKA (2007)T: 73.4C: 72.7T: 25/20C: 21/24

ACUChen Juan, 201746/46GDTO (2007) and GPCRNDTCMT: 45–76, 58.51C: 47–80, 59.23T: 25/21C: 27/19
Deng Jingming, 201540/40GDTO (2007)T: 60.0C: 62.0T: 17/23C: 15/25
Ding Minghui, 200930/30DCKO (1986)T: 59.37C: 58.93T: 8/22C:8/22
Guo Qian, 201979/79GDTO and DCTETCMKOT: 45–78, 56.06C:45–78, 56.06T: 38/41C: 38/41
Li Jianwu, 200830/30DCKO (1995)T: 53.0C: 55.6T: 11/19C:9/21
Li Jiangming, 201647/60NRT: 65.12C: 64.26T: 5/42C: 7/53
Liang Chao, 201630/30GDTO (2007)T: 61.4C: 60.3T: 22/8C: 21/9
Lin Ruyi, 201943/43GDTO (2007)T: 40–69, 60.05C:40–69, 59.52T: 22/21C: 24/19
Liu Jin, 201430/30GDTO (2007)T: 60.8C: 62.5T: 12/18C: 13/17
Luo Falan, 201842/42GDTO (2007) and GPCRNDTCMT: 49–67, 59.27C: 51–68, 58.45T: 18/24C: 19/23
Wang Lina, 201859/59NRT: 40–75, 52.13C: 41–77, 53.47T: 24/35C: 25/34
Wang Xiaoling, 201725/21DCKO (1995)T: 50–74, 61C: 44–75, 58T: 8/17C:2/19
Xu Chen, 201845/41DCKO (1995)T: 61.0C: 61.0T: 24/21C: 25/16
Xu Yahong, 201654/54GDTO and GPCRNDTCMT: 45–73, 54.3C: 45–75, 55.2T: 25/29C:24/30

C, control group; CDTEDSTCM, criteria for diagnosis and therapeutic effect of diseases and syndromes of traditional Chinese medicine; DCKO, diagnostic criteria of knee osteoarthritis; DTSTCM95D22S, diagnosis and treatment scheme of traditional Chinese medicine for 95 diseases in 22 specialties; DCTETCMKO, diagnostic criteria of therapeutic effect of traditional Chinese medicine on knee osteoarthritis; GDTO, guidelines for the diagnosis and treatment of osteoarthritis; GPCRNDTCM, guiding principles for clinical research of new drugs of traditional Chinese medicine; K–L, Kellgren–Lawwrence grading standard; NR, no report; PO, practical orthopaedics; T, trial group.